Guerrini R, Carra' G, Calo' G, Trapella C, Marzola E, Rizzi D, Regoli D, Salvadori S
Department of Pharmaceutical Sciences and Biotechnology Center, University of Ferrara, via Fossato di Mortara 19, 44100 Ferrara, Italy.
J Pept Res. 2004 Jun;63(6):477-84. doi: 10.1111/j.1399-3011.2004.00157.x.
Nociceptin/orphanin FQ (N/OFQ) is the endogenous ligand for the G-protein coupled receptor referred to as N/OFQ peptide (NOP) receptor. NOP receptor activation by N/OFQ modulates several biological functions both at central and peripheral level. Structure activity relationship (SAR) studies demonstrated that the N/OFQ sequence can be divided into a N-terminal tetrapeptide 'message' crucial for receptor activation and a C-terminal 'address' important for receptor binding. On the basis of this message/address concept we synthesized some chimeric compounds in which we substituted the natural message domain with the nonselective nonpeptide NOP ligand (8-Naphthalen-1-yl-methyl-4-oxo-1-phenyl-1,3,8-triaza-spiro[4,5]dec-3-yl)-aceticacid methyl ester (NNC 63-0532) and used as address domain the peptide sequences Thr-NH2, N/OFQ(5-9)-NH2, N/OFQ(5-13)-NH2 and N/OFQ(5-17)-NH2. All the compounds were pharmacologically evaluated in the electrically stimulated guinea-pig ileum. NNC 63-0532 produced a concentration-dependent inhibition of the electrically induced twitches showing, in comparison with N/OFQ, lower potency and higher maximal effects. In addition, contrary to N/OFQ, the effects of NNC 63-0532 were insensitive to the NOP selective antagonist [Nphe1, Arg14, Lys15]N/OFQ-NH2 (UFP-101) while prevented by naloxone. Similar results were obtained with NNC 63-0532/Thr-NH2 and NNC 63-0532/N/OFQ(1-9)-NH2. On the contrary, the inhibitory effects of NNC 63-0532/N/OFQ(5-13)-NH2 and NNC 63-0532/N/OFQ(5-17)-NH2 were slightly antagonized by UFP-101 while naloxone prevented the effects of the high but not of the low concentrations of the two ligands. These data indicate that it is possible to functionalize with the N/OFQ address sequence a nonpeptide NOP ligand for increasing its binding to the NOP receptor. Moreover, these results corroborate the idea that the 5-13 sequence represents the crucial core of the N/OFQ address domain.
孤啡肽/孤啡肽FQ(N/OFQ)是G蛋白偶联受体的内源性配体,该受体被称为N/OFQ肽(NOP)受体。N/OFQ激活NOP受体可在中枢和外周水平调节多种生物学功能。构效关系(SAR)研究表明,N/OFQ序列可分为对受体激活至关重要的N端四肽“信息”结构域和对受体结合重要的C端“地址”结构域。基于这一信息/地址概念,我们合成了一些嵌合化合物,其中用非选择性非肽NOP配体(8-萘-1-基甲基-4-氧代-1-苯基-1,3,8-三氮杂螺[4,5]癸-3-基)-乙酸甲酯(NNC 63-0532)取代天然信息结构域,并将肽序列苏氨酸-NH2、N/OFQ(5-9)-NH2、N/OFQ(5-13)-NH2和N/OFQ(5-17)-NH2用作地址结构域。所有化合物均在电刺激的豚鼠回肠中进行了药理学评估。NNC 63-0532对电诱导的抽搐产生浓度依赖性抑制,与N/OFQ相比,其效力较低但最大效应较高。此外,与N/OFQ相反,NNC 63-0532的作用对NOP选择性拮抗剂[Nphe1,Arg14,Lys15]N/OFQ-NH2(UFP-101)不敏感,但可被纳洛酮阻断。NNC 63-0532/苏氨酸-NH2和NNC 63-0532/N/OFQ(1-9)-NH2也得到了类似结果。相反,UFP-101对NNC 63-0532/N/OFQ(5-13)-NH2和NNC 63-0532/N/OFQ(5-17)-NH2的抑制作用有轻微拮抗作用,而纳洛酮可阻断两种配体高浓度而非低浓度时的作用。这些数据表明,用N/OFQ地址序列对非肽NOP配体进行功能化修饰,可增加其与NOP受体的结合。此外,这些结果证实了5-13序列代表N/OFQ地址结构域关键核心的观点。